Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The gonadotropin-releasing hormone 1 receptor (GnRH1R) is a seven-transmembrane G protein-coupled receptor located primarily on pituitary gonadotrope cells, as well as extrapituitary sites including reproductive and some cancer tissues[1][4][6]. It mediates the physiological actions of GnRH—a decapeptide released by the hypothalamus—that regulates the synthesis and secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), playing a pivotal role in the control of reproduction[4][6][7][9]. Structurally, GnRH1R is notable for lacking the cytoplasmic C-terminal tail present in most class A GPCRs, leading to unique receptor activation and ligand-binding properties[1][2][3]. Pharmacologically, both agonists and antagonists for GnRH1R are widely used in reproductive medicine, hormone-dependent cancer therapy, and the management of diseases like endometriosis and infertility[3][5][6].
Agonists stimulate GnRH1R, causing receptor-mediated signaling and, with continued exposure, receptor downregulation and suppression of gonadotropin secretion. Antagonists block GnRH1R, inhibiting gonadotropin release and lowering sex steroid levels.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gonadotropin-releasing hormone 1 receptor (GnRH1R).